Wragge advises biopharmaceutical company arGEN-X on collaboration and alliance
Wragge Lawrence Graham & Co’s life sciences team has advised Netherlands- and Belgium-based biopharmaceutical company arGEN-X on its first collaboration with Bayer to discover and develop therapeutic antibody candidates and on a strategic alliance with Shire. Both deals were completed in the same week.
Sign in or Register to continue reading this article
It's quick, easy and free!
Why register to The Lawyer
More relevant to you
News from Wragge Lawrence Graham & Co
News from The Lawyer
Briefings from Wragge Lawrence Graham & Co
2015 has seen two separate prosecutions instigated for alleged failure to notify the Secretary of State of proposed collective redundancies – the City Link and USC cases.
WLG’s employment & equalities experts bring you the latest developments that may affect your business – what they are, and what you can do about them.